Investigator Site 1117 — Washington D.C., District of Columbia

Investigator Site 1117 is a clinical research site located in Washington D.C., District of Columbia, United States 20422.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 1117 has participated in 1 clinical trials.

Therapeutic areas: Acute Coronary Syndrome.

Sponsors: Anthera Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 1117?

Investigator Site 1117 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 1117 conducted?

Investigator Site 1117 has 1 clinical trials on record. Their work covers Acute Coronary Syndrome.

Is Investigator Site 1117 accredited by Crixeo Health?

Investigator Site 1117 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 1117?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.